Le Registre des lobbyistes
Pfizer Canada ULC
Objets poursuivis : Renseignements rétrospectifs : | Informal communications, phone calls, written communications, meetings, presentations with: ministers, members of parliament, senators, political advisors and civil servants. |
Objets poursuivis : Renseignements prospectifs : | Informal communications, phone calls, written communications, meetings, presentations with: ministers, members of parliament, senators, political advisors and civil servants. |
Catégories | Description |
---|---|
Proposition législative, Règlement | Access to Information Act & Regulations |
Politique ou programme | Adverse Event Reporting Policies |
Politique ou programme | Auditor General Reports |
Politique ou programme | Broad Pharmaceutical Policy Approaches |
Règlement | Canadian Access to Medicines Regime (consultations) |
Politique ou programme | Canadian Institute of Health Researchers (CIHR) and other Research Oriented Spending Programs |
Politique ou programme | Canadian Strategy for Cancer Control |
Politique ou programme | Clinical Assessment of Abuse Liability for Drugs with Central Nervous System (CNS) Activity-Draft Guidance |
Politique ou programme | Clinical Evaluation of QT/QTc Interval Prolongation & Proarrhythmic Potential for Non-Antarrythmic Drugs-Adoption of International Conference on Harmonization (ICH) Guidelines (Health Canada document: QT/QTc Interval Prolongation: Guidance for Product Monograph Content or see: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/qtqtc/qt_pm_mp_e.html#1) |
Règlement | Clinical Trials Regulations (Division 5) |
Proposition législative, Politique ou programme | Competition Act Amendments |
Politique ou programme | Cost Recovery & Performance |
Politique ou programme | Cross Border Trade |
Règlement | Data Protection/Patented Medicines Notice of Compliance Regulations [PM(NOC) Regulations] |
Politique ou programme | Department of National Defense Health Benefits Program |
Subvention, Contribution ou autre avantage financier | Donations by Corporations of Property held in inventory (donation of pharmaceutical products) |
Règlement | Draft 2007 Good Manufacturing Practices (GMPs) |
Proposition législative | Drug Product Review & Approval System |
Règlement | Drug Product Review & Approval System / Regulations (filing formats of drug submissions, i.e. electronic Common Technical Document (eCTD) providing review tools currently not listed in the regulations) |
Politique ou programme | Drug Safety |
Politique ou programme | Drugs Review & Approval Systems (Improving the efficiency of over-the-counter and natural health products) |
Politique ou programme | Federal/Provincial/Territorial Pharmaceutical Management Initiative: Canadian Agency for Drugs and Technologies in Health (CADTH) |
Politique ou programme | Federal/Provincial/Territorial Pharmaceutical Management Initiative: Canadian Expert Drug Advisory Committee (CEDAC) ) |
Politique ou programme | Federal/Provincial/Territorial Pharmaceutical Management Initiative: Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) |
Politique ou programme | Federal/Provincial/TerritorialPharmaceutical Management Initiative: Common Drug Review (CDR) |
Politique ou programme | Federal/Provincial/Territorial Pharmaceutical Management Initiative: National Prescription Drug Utilization Information System (NPDUIS) |
Règlement, Projet de loi ou résolution | Federal Accountability Act |
Politique ou programme | Food & Drug Act & Regulatory Policies - Good Manufacturing Practices and Establishment Licensing |
Règlement | Food & Drug Regulations (Good Manufacturing Practices & Establishment Licensing) |
Règlement | Food & Drugs Act (Drug Review & Approval regulations, Amendments to FDA, Data protection, Direct-to-Consumer Advertising Regs, New Substance Notification Regulations, Clinical Registry and Disclosure Regulation, GMP & Establishment Licensing) |
Proposition législative | Food and Drugs Act (Cross Border Trade [CBT], Drug Export Restrictions, Regulatory Policies) |
Politique ou programme | Health Canada Memorandum of Understanding with the US Food and Drugs Administration |
Politique ou programme | Health Canada Non-insured Health Benefits Program |
Politique ou programme | Health Canada Pharmaceutical and Biological Policies and Applicable Guidelines |
Politique ou programme | Health Canada Pharmaceutical Policies and Guidelines |
Politique ou programme | Health Canada Probationary / Progressive Licensing Framework |
Politique ou programme | Health Canada Subsequent Entry Biologics Policy |
Politique ou programme | Health Canada Therapeutic Access Strategy |
Proposition législative | Health Protection Act (Legislative Renewal) |
Politique ou programme | Health Protection and Food Branch External Changing Program |
Politique ou programme | Health Research Funding |
Politique ou programme | Improving the efficiency of the drug review and approval process |
Politique ou programme | Innovation Agenda |
Politique ou programme | Management of Submission Poilcy |
Politique ou programme | National Pharmaceutical Strategy |
Proposition législative | Patent Act |
Règlement | Patent Act (NoC Linkage) Regulations |
Règlement | Patent Act (Patented Medicines (Notice of Compliance)) Regulations - Amendments to |
Règlement, Projet de loi ou résolution | Patented Medicine Prices Review Board (PMPRB) Regulations |
Politique ou programme | Patent Policies |
Proposition législative | Personal Information Protection and Electronic Documents Act |
Politique ou programme | Personal Use Importation of Products for Livestock Production |
Politique ou programme | Pharmacogenomics/Biomarkers |
Règlement, Politique ou programme | PMPRB (Patented Medicine Prices Review Board) (Appointment policies/guideline changes/regulations) |
Proposition législative | Pre-Budget Consultations |
Proposition législative | Privacy Act |
Politique ou programme | Proposed Clinical Trials Registry-Disclosure |
Politique ou programme | Public Service Health Care Plan |
Politique ou programme | Royal Canadian Mounted Police National Health Services |
Politique ou programme | Science and Technology Policy |
Politique ou programme | Smart Regulations (Specific, measurable, attainable, realistic, timelines Regulations) |
Politique ou programme | Trade (related to border opening for live cattle for reproduction) |
Politique ou programme | Vaccine Review and Approval System (Canadian Food Inspection Agency) |
Règlement | Vet Biologics Regulatory Reveiw (CFIA) - New Product Licensing Guidelines, Licensing of United States Department of Agriculture approved products for companion animals |
Règlement | Vet Biologics Regulatory Review (Canadian Food Inspection Agency (CFIA)) - New product Licensing Guidelines |
Règlement | Vet Biologics Regulatory Review (Canadian Food Inspection Agency) - Conditional Licensing Guidelines |
Politique ou programme | Veterans Affairs Drug Benefits Plan |
Proposition législative | Veterinary Drug Distribution (VDDs) Document on Antimicrobial Categorization |